IDEAS home Printed from https://ideas.repec.org/a/bdz/joimer/v1y2022i2p28-35.html

Epoetin Alfa: a Creative Way to Treat Anemia

Author

Listed:
  • Bofan Xu

    (King’s College London)

Abstract

The use of epoetin alfa has been one of the most relevant trends in the past years, therefore, it is important to understand how epoetin alfa differs from other biopharmaceuticals and to summarise the innovative nature of epoetin alfa. This paper aims at why the biopharmaceutical represents innovation in terms of lead-discovery, drug development and fulfilling a previously unmet treatment need. As far as we know, studies on the creativity of epoetin alfa are lacking in the main literature. This paper reveals that the purpose of epoetin alfa’s therapy and current treatment modalities, general principles of the drug discovery process, the creativity in medicinal chemistry & pharmacology of epoetin alfa, choosing the target and sources of compound supply, intellectual property considerations in drug discovery & development, the drawbacks of epoetin alfa and the creativity of epoetin alfa. The contribution of the present research involves that summarising the innovation of epoetin alfa.

Suggested Citation

  • Bofan Xu, 2022. "Epoetin Alfa: a Creative Way to Treat Anemia," Journal of Innovations in Medical Research, Paradigm Academic Press, vol. 1(2), pages 28-35, September.
    • Handle: RePEc:bdz:joimer:v:1:y:2022:i:2:p:28-35
    DOI: 10.56397/JIMR/2022.09.04
    as

    Download full text from publisher

    File URL: https://www.paradigmpress.org/jimr/article/view/197/165
    Download Restriction: no
    File URL: https://libkey.io/10.56397/JIMR/2022.09.04?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bdz:joimer:v:1:y:2022:i:2:p:28-35. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Editorial Office (email available below). General contact details of provider: https://www.paradigmpress.org/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.